Indicators of clinical and laboratory findings in patients who was suffered from Covid in Uzbekistan. (Retrospective and Prospective Analysis)
Abstract
A comparative analysis of clinical, anamnestic and laboratory parameters of patients with COVID-19 was carried out using the method of retrospective and prospective examination. It was found that during treatment with antiviral drugs, a quarter of patients had changes of cytolysis markers. It was also shown that patients with comorbidity were more common in a prospective study.
Keywords
Covid-19, retrospective study, prospective analysisHow to Cite
References
Green M.S., Zeniman J., Cohen D., Wither I., Baliser R.D. /Risk Assessment and Risk Communication
Strategies for Bioterrorism Preparedness //Springer Science & Business Media; Dordrecht, The
Netherlands: 2007
Conrow E. H., Polmann L. D. / Effective risk management: some keys to success, second edition.
Understanding. 2004; 6:44. doi: 10.1002/inst.20046244.
De las Heras-Pedrosa K., Sanchez-Nunez P., Pelaez H.I.
/ Sentiment analysis and understanding of
emotions during the COVID-19 pandemic in Spain and its impact on digital ecosystems. // Intern. J.
Environment. Res. Healthcare. 2020; 17:5542. doi: 10.3390/ijerph17155542.
Iglesias-Sanchez P.P., Witt G.F.V., Cabrera F.E., Hambrino-Maldonado C. / Contagion of the senses
during the COVID-19 pandemic crisis: a case of lockdown in Spain. // International J. Environment.
Res. Healthcare. 2020; 17:5918. doi: 10.3390/ijerph17165918.
Pavlic J., Tomasic T., Kozhuh I. / The impact of new technologies on the effectiveness of product
placement: a preliminary study from the perspective of interactive marketing. //J. Res. To interact.
Mark. 2021: 10.1108/JRIM-02-2021-0041.
Popova A.Yu. et al. / Experience of international cooperation in organizing anti-epidemic measures by
healthcare institutions in the context of the covid-19 pandemic in the Republic of Uzbekistan, DOI:
21055/0370-1069-2021-3-122-128
European Commission. Coronavirus: Commission presents EU vaccine strategy. 2020. [(accessed 24
January 2022)]. https://ec.europa.eu/commission/presscorner/detail/en/ip_20_1103
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. /Clinical Characteristics of Coronavirus
Disease 2019 in China. // N Engl J Med. 2020. [Epub ahead of print]
https://doi.org/10.1056/NEJMoa2002032
Sobirova G.N., Bafoyeva Z.O. Determination and Analysis of Changes in the Hepatobiliary System in
Patients with Covid-19 // American Journal of Medicina and Medical Sciences.- 2021.-11(2).- P.145-
Sobirova G. N., Bafoeva Z.O., Usmankhodzhayeva A. A. Сlinical and biochemical parameters of
patients with Сovid-19 with impaired liver function before and after treatment.// Тошкент тиббиёт
академияси, Ёш олимлар журнали.- Тошкент.- 2023.- №1(06).- Б. 105-112
Uzbekistan confirms first coronavirus case — govt.
Available at:
https://www.reuters.com/article/health-coronavirus-uzbekistan-idUSL8N2B802F (accessed
01.2022).
Jasim SA, Mahdi RS, Bokov DO, Najm MAA, Sobirova GN, Bafoyeva ZO, Taifi A, Alkadir OKA,
Mustafa YF, Mirzaei R, Karampoor S./The deciphering of the immune cells and marker signature in
COVID-19 pathogenesis: An update //J Med Virol . 2022 Jul 14;10.1002/jmv.28000. doi:
1002/jmv.28000. Epub ahead of print. PMID: 35835586; PMCID: PMC9350195. С.1-21
Chan, J.F., Kok, K.H., Zhu, Z., Chu, H., To, K.K., et al. (2020) Genomic Characterization of the 2019
Novel Human-Pathogenic Coronavirus Isolated from a Patient with Atypical Pneumonia after Visiting
Wuhan. Emerging Microbes & Infections, 9, 221-236. https://doi.org/10.1080/22221751.2020.1719902
License
Copyright (c) 2025 Nabiyeva Dildora Abdumalikovna, Makhfuza Rustamovna Bekchanova
This work is licensed under a Creative Commons Attribution 4.0 International License.